| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/22/2006 | EP1635891A2 Pharmaceutical composition to prevent and treat epithelial wounds, immunomodulating pharmaceutical composition, pharmaceutical composition, insecticide, insecticide composition, insecticide use of lectin km+ to treat cicatrizations, use of lectin km+ to prepare immunomodulating medicament |
| 03/22/2006 | EP1635866A2 Modified antiviral peptides with increased activity and cell membrane affinity |
| 03/22/2006 | EP1635864A2 Immunogenic compositions comprising multiple gonococcal antigens |
| 03/22/2006 | EP1635860A2 Use of vegf-c or vegf-d in reconstructive surgery |
| 03/22/2006 | EP1635856A2 Saposin c-dops: a novel anti-tumor agent |
| 03/22/2006 | EP1635855A2 Selective r-cadherin antagonists and methods |
| 03/22/2006 | EP1635692A2 Monitoring immunologic, hematologic and inflammatory diseases |
| 03/22/2006 | EP1635629A2 Plant transcriptional regulators of disease resistance |
| 03/22/2006 | EP1597278A4 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 03/22/2006 | EP1497415A4 Cytokine receptor |
| 03/22/2006 | EP1461436A4 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 03/22/2006 | EP1404814A4 Nuclear fertility restorer genes and methods of use in plants |
| 03/22/2006 | EP1149171B1 Foamy virus vectors for expressing foreign genes in mammals and the use thereof |
| 03/22/2006 | EP1129191B1 Methods of diagnosing or treating neurological diseases |
| 03/22/2006 | EP1075673A4 Methods of determining protein activity levels using gene expression profiles |
| 03/22/2006 | EP1017799B1 Mutant mhc class i molecules |
| 03/22/2006 | EP1008603B1 Soluble polypeptides consisting on the first coiled coil domain of human and mouse epimorphin. |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | EP0914456B1 Gene expression in monocytes and macrophages |
| 03/22/2006 | EP0864645B9 Negative-strand rna virus vector having autonomously replicating activity |
| 03/22/2006 | EP0839184B1 Synthetic hpv11 virus-like particles |
| 03/22/2006 | EP0832239B1 Camp factor of streptococcus uberis |
| 03/22/2006 | CN1751125A Mixing and matching TC proteins for pest control |
| 03/22/2006 | CN1751122A Fusion proteins of interferon alpha muteins with improved properties |
| 03/22/2006 | CN1751065A Gene resistant to aphis gossypii |
| 03/22/2006 | CN1751064A Hsp60 from arthrobacter |
| 03/22/2006 | CN1751063A Peptide derived from a VCA-p18 capside antigen of the epstein-barr virus and the use thereof |
| 03/22/2006 | CN1751062A Water soluble animal muscle protein product |
| 03/22/2006 | CN1750842A Analogues of GLP-1 |
| 03/22/2006 | CN1749397A Bi-recombinant active carrier vaccine of co-expression pig gyrate virus and foot and mouth disease virus |
| 03/22/2006 | CN1749395A Cloning and expression of Japan blood flukes SJCXSWL 02 gene and DNA vaccine |
| 03/22/2006 | CN1749394A Cloning and expression of Japan blood flukes HGPRT gene and DNA vaccine |
| 03/22/2006 | CN1749275A Method for processing hydrolytic fish skin collagen |
| 03/22/2006 | CN1749274A Separating and purifying method for new recombinant human interferon alpha2b |
| 03/22/2006 | CN1749273A Human new protein hCRISP56 and its code sequence |
| 03/22/2006 | CN1749272A Human new protein hBTBD56 and its code sequence |
| 03/22/2006 | CN1749271A Human new protein Hunsp 18 and its code sequence |
| 03/22/2006 | CN1748787A Pharmaceutical preparation containing p40 molecule or its gene |
| 03/22/2006 | CN1246464C Novel transcriptional factor enhancing resistance of plants to osmotic stress |
| 03/22/2006 | CN1246458C Human cervical cancer 2 protooncogene and protein encoded therein |
| 03/22/2006 | CN1246457C Human TSC403 gene and human ING1L gene |
| 03/22/2006 | CN1246456C Lactic acid bacteria capable of reducing individual's tendency to develop allergic reactions |
| 03/22/2006 | CN1246333C Receptor in the EDb Fibronection domain |
| 03/22/2006 | CN1246332C Method of producing high purity postmenopause urine gonadotropin |
| 03/22/2006 | CN1246331C Method for purifying recombined human interferon alpha-2b by using affinity chromatography of expanded bed pigment |
| 03/22/2006 | CN1246330C Human tumor generating and metastasis promoting acceptor molecule and its encoding gene and application |
| 03/22/2006 | CN1246329C Mouse tumor generating and metastasis promoting acceptor and its encoding gene and application |
| 03/22/2006 | CN1246040C Process to make a sustained release formulation |
| 03/22/2006 | CN1246038C Systemic delivery of oral vaccines of botulinus toxin |
| 03/21/2006 | USRE39034 synthetic polypeptides used to control semen binding to oocytes; fertility and/or antifertility agents |
| 03/21/2006 | US7015316 persephin is a member of the GDNF-Neurturin family of growth factors; Glial-derived neurotrophic factor (GDNF); promotes survival of mesencephalic neuronal cells; nucleic acids of given sequences |
| 03/21/2006 | US7015315 first region having 2'-O-alkyl substituted nucleotide units where the alkyl has at least 2 carbon atoms, and a second region having 2'-deoxy sugar moieties, and which includes phosphorothioate linkages; nuclease resistance; hybridizes to single stranded DNA or RNA |
| 03/21/2006 | US7015313 use as a diagnostic agent or a carrier protein conjugated to various anti-cancer drugs owing to its ability to specifically recognize N-glycolylneuraminic acid; antiproliferative agent; called lectin PPA (Philyra pisum agglutinin) |
| 03/21/2006 | US7015311 That binds to a neurturin polypeptide of given sequences that promotes survival of superior cervical ganglion cells or nodose ganglion cells; can be used to detect and monitor patient levels of neurturin |
| 03/21/2006 | US7015310 Oxidation reduction sensitive green fluorescent protein variants |
| 03/21/2006 | US7015308 human Desert hedgehog protein of given sequence; a drug target: efficacy in elucidation of hereditary morphological abnormalities in humans to establish their treatments and diagnoses |
| 03/21/2006 | US7015195 Treatment of bone disorders with skeletal anabolic drugs |
| 03/21/2006 | US7015194 Mixture of factor vii and btissue factor pathway inhibitor; blood coagulation |
| 03/21/2006 | US7015193 Compositions and methods to control bleeding |
| 03/21/2006 | US7015192 synthetic hexapeptides or oligopeptides used as neurosecretion antagonists; bloking release of catecholamines; wrinkling and aging resistance |
| 03/21/2006 | US7015190 Administering peptides, mimetics or nucleic acids to interfere with cAMP binding proteins or with DNA so as to derepress cAMP-responsive gene expression; cognition activators; learning enhancement |
| 03/21/2006 | US7015033 a nucleic acid molecule encoding a non-proteolytic mutant of a Haemophilus Hin47 protein wherein said Hin47 protein is mutated at amino acid 91, 121 or 197 |
| 03/21/2006 | US7015024 Compositions containing recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences |
| 03/21/2006 | US7015023 A hormone binding domain linked to a beta -glucuronidase enzyme by a peptide containing a caspase cleavage site (beta -glucuronidase is inactive due to linkage to the hormone binding domain), release of the beta -glucuronidase through caspase split |
| 03/21/2006 | US7015021 Method for making purified plasminogen activator-inhibitor type 1 (PAI-1) and purified PAI-1 made therefrom |
| 03/21/2006 | US7015015 Nucleotide sequences coding polypeptide for use in treatment of diabetes, epilepsy, depression, ischemia and muscle disorders |
| 03/21/2006 | US7015007 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 03/21/2006 | US7015004 Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance |
| 03/21/2006 | US7015001 Comprises nucleotide sequences coding spinosyn-A biosynthetic enzyme for preparing pesticides; biological pest control agents |
| 03/21/2006 | US7014855 inducing an immune response against a peptide component of an amyloid deposit; active administration of an immunogen or passive administration of an antibody or an active fragment or derivative of the antibody; Alzheimer's disease |
| 03/21/2006 | US7014853 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 03/21/2006 | US7014823 comprises two energy transmitting stripes across an ATP well, actin filaments and a movable member coated with myosin that moves linearly as a result of actin/myosin interaction; nanoscale mechanical devices, pumps, valves |
| 03/21/2006 | CA2266743C Adenoviral vectors for mutants of human interleukin 6 (hil-6) with hil-6 antagonist activity, pharmaceutical compositions therewith and their uses |
| 03/21/2006 | CA2236206C Heparin chromatography of erythropoietins |
| 03/21/2006 | CA2191406C Process for removing aromatic compounds from product-containing solutions |
| 03/21/2006 | CA2182272C Modified papilloma virus l2 protein and vlps formed therefrom |
| 03/21/2006 | CA2154080C Novel anticoagulant cofactor activity |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/21/2006 | CA1341502C Method for the production of erythropoietin |
| 03/16/2006 | WO2006029393A2 Process for preparation of mixtures of polypeptides using purified hydrobromic acid |
| 03/16/2006 | WO2006029338A2 Modified hiv-1 envelope proteins |
| 03/16/2006 | WO2006029224A2 Methods of using death receptor ligands and cd20 antibodies |
| 03/16/2006 | WO2006028714A1 Muteins of fibroblast growth factor 21 |
| 03/16/2006 | WO2006028655A2 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 03/16/2006 | WO2006028561A2 Novel purified fabi polypeptides from fransicella tularensis |
| 03/16/2006 | WO2006028492A2 hC1Q/TNF7 AND USES THEREOF |
| 03/16/2006 | WO2006027780A2 Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same |
| 03/16/2006 | WO2006027701A2 Fas associated factor 1 |
| 03/16/2006 | WO2006027584A2 Vaccines against neisseria |
| 03/16/2006 | WO2006027468A2 Hla-dp4 restricted t cd4+ du vih epitopes and the use thereof |
| 03/16/2006 | WO2006027207A1 Transport protein which is used to introduce chemical compounds into nerve cells |
| 03/16/2006 | WO2006027147A2 Diagnostics and therapeutics for diseases associated with adrenomedullin receptor (amdr) |
| 03/16/2006 | WO2006027117A2 Diagnostics and therapeutics for diseases associated with cysteinyl leukotriene receptor 2 (cyslt2) |
| 03/16/2006 | WO2006026994A1 Crystal structure of house dust mite allergen der p 1 |
| 03/16/2006 | WO2005121175A9 Env polypeptide complexes and methods of use |
| 03/16/2006 | WO2005121168A3 Heparin binding peptide |
| 03/16/2006 | WO2005118881A3 Carrier tests for polycystic kidney disease in the cat |
| 03/16/2006 | WO2005118813A3 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| 03/16/2006 | WO2005117538A9 METHODS AND COMPOSITIONS FOR INHIBITING ABAD/Aβ PROTEIN INTERACTION |
| 03/16/2006 | WO2005115306A3 Keratin-binding polypeptides |